Literature DB >> 325765

Calculations on long-term graft and patient survival in human kidney transplantation.

G Opelz, M R Mickey, P I Terasaki.   

Abstract

Long-term survival rates of human kidney transplants were found to decline at constant rates following the second year after transplantation. The slopes of decline were statistically significantly different for cadaver, parent-to-child, and HLA-identifical sibling transplants, resulting in graft survival half-life times during the constant risk phase of 7.5, 11, and 34 years, respectively. The corresponding patient survival half-life times were 12, 19, and 36 years, respectively. A highly significant difference in long-term survival risk was found when seven transplant centers that had been selected on the basis of their good 1-year graft survival results were compared with seven centers known to have a poor 1-year survival rate. The cadaver graft half-life times during the constant risk phase were 3.3 years for the "poor" centers and 8.7 years for the "good" centers. Thus, although histocompatibility obviously is a main factor in determining long-term survival risk, additional factors such as clinical treatment regimen appear to be influential. Knowledge of the long-term risk constants for the different transplant categories can be applied for the projection of success rates as well as retransplant and dialysis needs.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 325765

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  11 in total

1.  The late results of renal transplantation and the importance of chronic rejection as a cause of graft loss.

Authors:  M C Foster; P W Wenham; P A Rowe; R P Burden; A G Morgan; R E Cotton; R W Blamey
Journal:  Ann R Coll Surg Engl       Date:  1989-01       Impact factor: 1.891

2.  Effect of HLA mismatch in African-Americans.

Authors:  V Scantlebury; D Gjertson; M Eliasziw; P Terasaki; J Fung; R Shapiro; A Donner; T E Starzl
Journal:  Transplantation       Date:  1998-02-27       Impact factor: 4.939

Review 3.  Recent developments in dialysis and transplantation.

Authors:  D B Gradus; R N Fine
Journal:  Indian J Pediatr       Date:  1988 Jul-Aug       Impact factor: 1.967

Review 4.  Pancreas and islet transplantation. II. Clinical trials.

Authors:  D E Sutherland
Journal:  Diabetologia       Date:  1981-04       Impact factor: 10.122

5.  Transplantation immunology of penetrating keratoplasty.

Authors:  W J Stark
Journal:  Trans Am Ophthalmol Soc       Date:  1980

6.  Ten-year experience with cyclosporine as primary immunosuppression in recipients of renal allografts.

Authors:  N L Tilney; A Chang; E L Milford; W D Whitley; J M Lazarus; E L Ramos; T B Strom; C B Carpenter; R L Kirkman
Journal:  Ann Surg       Date:  1991-07       Impact factor: 12.969

7.  HLA and cross-reactive antigen group matching for cadaver kidney allocation.

Authors:  T E Starzl; M Eliasziw; D Gjertson; P I Terasaki; J J Fung; M Trucco; J Martell; J McMichael; V Scantlebury; R Shapiro; A Donner
Journal:  Transplantation       Date:  1997-10-15       Impact factor: 4.939

8.  100 HLA-identical sibling transplants. Prognostic factors other than histocompatibility.

Authors:  N L Ascher; R L Simmons; H Noreen; J VanHook; R J Howard; D E Sutherland; J S Najarian
Journal:  Ann Surg       Date:  1979-02       Impact factor: 12.969

9.  Kidney transplant half-life (t[1/2]) after rapid discontinuation of prednisone.

Authors:  Arthur J Matas; Kristen Gillingham; Raja Kandaswamy; Ty B Dunn; William D Payne; David E R Sutherland; Abhinav Humar
Journal:  Transplantation       Date:  2009-01-15       Impact factor: 4.939

10.  Characteristics of cadaveric renal allograft recipients developing chronic rejection.

Authors:  M C Foster; P A Rowe; M J Dennis; A G Morgan; R P Burden; R W Blamey
Journal:  Ann R Coll Surg Engl       Date:  1990-01       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.